ReviewAntioxidants (Basel, Switzerland)2026
Molecular Mechanisms of Obesity-Associated Oxidative Stress and Therapeutic Strategies.
Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Obesity is a chronic metabolic disorder characterized by excessive adipose tissue accumulation and associated with systemic oxidative stress, mitochondrial dysfunction, and chronic low-grade inflammation. Adipose tissue dysfunction promotes the overproduction of reactive oxygen species through multiple mechanisms, including NADPH oxidase activation, mitochondrial electron transport chain leakage, and endoplasmic reticulum stress via mitochondria-associated ER membranes. The resulting oxidative stress damages lipids, proteins, and DNA, while activating redox-sensitive signaling pathways that perpetuate inflammation and insulin resistance. Moreover, obesity impairs endogenous antioxidant defense systems, including reduced activity of superoxide dismutase, glutathione peroxidase, and catalase, as well as magnesium deficiency that compromises glutathione synthesis. This review synthesizes current knowledge of molecular mechanisms linking obesity to oxidative stress and discusses key biomarker categories, including lipid peroxidation products, protein oxidation markers, DNA damage markers, adipokine ratios, and microRNAs. We also evaluate therapeutic strategies targeting obesity-associated oxidative stress, with emphasis on lifestyle interventions, pharmacological agents, and dietary compounds including resveratrol, curcumin, lycopene, and astaxanthin. Understanding the relationship between obesity and oxidative stress is essential for developing mechanism-directed therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.